Stay updated on MGL-3196 in NASH Patients: Clinical Trial
Sign up to get notified when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.

Latest updates to the MGL-3196 in NASH Patients: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedSignificant updates to status notices and new genetics topic, plus revision bump; removal of the old 'No Results Posted' note.SummaryDifference4%
- Check20 days agoChange DetectedAdds v3.1.0 revision and removes several high-importance topics (drug safety and related subtopics) and an older revision tag v3.0.2; overall, decreases coverage of safety-related content.SummaryDifference0.8%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. There are no changes to core content, pricing, or other key information.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated to include information on non-alcoholic fatty liver disease, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.6%
- Check48 days agoChange DetectedThe web page has been updated to include new information about the treatment of Fatty Liver Disease, specifically highlighting the drug Resmetirom and its clinical evaluation. Additionally, the facility name and specific locations have been added, while some previous location details and genetic resources have been removed.SummaryDifference5%
- Check63 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to MGL-3196 in NASH Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.